Table 2 Distribution of the studied cases according to clinical data (n = 110)
Clinical data | No. | % |
|---|---|---|
Age at the beginning of addiction | ||
< 18 | 15 | 13.6 |
18–35 | 85 | 77.3 |
> 35 | 10 | 9.1 |
Family history of addiction | ||
No | 63 | 57.3 |
Yes | 47 | 42.7 |
Duration of addiction (years) | ||
Less than 1 | 6 | 5.5 |
1 < 5 | 69 | 62.7 |
5 < 10 | 26 | 23.6 |
> 10 | 9 | 8.2 |
Previous hospitalization | ||
No | 72 | 65.5 |
1 < 3 times | 33 | 30.0 |
> 3 times | 5 | 4.5 |
Number of substances | ||
1 | 33 | 30.0 |
2–4 substances | 33 | 30.0 |
> 4 substances | 44 | 40.0 |
Main cause of substance addictions | ||
Peer pressure | 29 | 26.4 |
Aggressive behavior in childhood. | 8 | 7.3 |
Neglect from parents or guardians. | 11 | 10.0 |
Having access to drugs | 16 | 14.5 |
Experimenting with drugs or other substances. | 0 | 0.0 |
Curiosity | 14 | 12.7 |
Psychological and family problems | 20 | 18.2 |
Free time | 12 | 10.9 |
Abused substances* | ||
Opioids “Tramadol- Heroin- Morphine-Codeine” | 6 | 5.5 |
CNS Depressants “alcohol, barbiturates, anti-anxiety tranquilizers” | 6 | 5.5 |
CNS Stimulants “cocaine, amphetamines, and methamphetamine” | 6 | 5.5 |
Hallucinogens “Cannabis-LSD-MDMA-Ketamine- Pilocybin” | 8 | 7.3 |
Inhalants” volatile solvents-Aerosol sprays-Gases-Nitrites” | 3 | 2.7 |
Synthetic drugs | 5 | 4.5 |
Opioids + Hallucinogens | 17 | 15.5 |
Opioids + CNS depressants | 21 | 19.1 |
Opioids + CNS Stimulants | 13 | 11.8 |
CNS stimulants + Hallucinogens | 11 | 10.0 |
Hallucinogens + Inhalants | 8 | 7.3 |
CNS depressants + Hallucinogens | 4 | 3.6 |
CNS stimulants + Inhalants | 2 | 1.8 |